Revelation Biosciences, Inc. Share Price

Revelation Biosciences, Inc. Share Price

NASDAQ: REVB | Micro Cap
$3.72
+$0.22 (6.29%) Last updated on 28 Oct, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Revelation Biosciences, Inc. Stock Performance

Open
$3.72
Prev. Close
$3.50
Circuit Range
N/A
Day Range
$3.72 - $3.72
Year Range
$0.45 - $3.80
Volume
187
Average Traded
$3.72

Revelation Biosciences, Inc. Share Price Today

As of 29 October 2026, Revelation Biosciences, Inc.'s share price is $3.72. The stock opened at $3.72, compared to its previous close of $3.50. During today's trading session, Revelation Biosciences, Inc.'s share price traded between $3.72 and $3.72, with an average price of $3.72. Over the past 52 weeks, the stock has recorded a high of $3.80 and a low of $0.45. In terms of performance, Revelation Biosciences, Inc.'s share price has risen by 223.48% over the last six months and is up 200.00% on a year-on-year basis.

Revelation Biosciences, Inc. Share Price Chart

Line chart of the Revelation Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 3.51 to 3.76, ending at 3.72.
$3.72$3.72
L
Show Current Price
H

Revelation Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.31M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-33.74
Revenue (TTM)
$0.00
Return On Equity (TTM)
-190.74%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.06%

Revelation Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.68-$2.51-$8.69-$3.32
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A46.37%-246.22%61.80%

Revelation Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$10.83-$0.12-$15.04-$14.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A98.89%-12433.33%1.13%

About Revelation Biosciences, Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

Revelation Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.77
$3.72
+353.66%
Sep 2026
$0.98
$0.82
-20.39%
Aug 2026
$1.01
$1.03
+8.42%
Jul 2026
$1.04
$0.95
-7.77%
Jun 2026
$1.06
$1.03
-6.36%
May 2026
$1.05
$1.10
-4.35%
Apr 2026
$1.21
$1.15
-6.50%
Mar 2026
$1.30
$1.23
-6.82%
Feb 2026
$1.89
$1.32
-34.16%
Jan 2026
$0.81
$2.00
+152.20%
Dec 2025
$0.98
$0.80
-17.70%
Nov 2025
$1.19
$0.97
-22.10%

REVB Share Price FAQs